External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ESGCT 2023
Roche and Genentech at

ESGCT 2023

October 24 - October 27
Brussels, Belgium
esgctcongress.com
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
03:00 PM
Duration 90mins Brussels, Belgium
T-cell response to micro-dystrophin in a patient treated with delandistrogene moxeparvovec gene therapy: A case of immune-mediated myositis
S Khan, H Haegel, A Hollenstein, C Wandel, K Wagner, D Asher, DA Griffin, RA Potter, I Moeller, T Singh, LR Rodino-Klapac
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.